Richard Czerniak
Takeda (United States)(US)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Helicobacter pylori-related gastroenterology studies, Diabetes Treatment and Management, Antiplatelet Therapy and Cardiovascular Diseases, Bioactive Compounds and Antitumor Agents
Most-Cited Works
- → Naturally occurring quinones as potential bioreductive alkylating agents(1981)214 cited
- → Gender-Based Differences in Pharmacokinetics in Laboratory Animal Models(2001)129 cited
- → Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism(1995)104 cited
- → Assay of 1-nitropropane, 2-nitropropane, 1-azoxypropane and 2-azoxypropane for carcinogenicity by gavage in Sprague—Dawley rats(1987)79 cited
- → Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA methylating species by rat liver and rat colon mucosa in vivo(1987)24 cited
- Natural quinones as quinonemethide precursors--ideas in rational drug design.(1986)
- → Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure(2020)19 cited
- → Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐esophageal reflux disease and partial response to a healing dose of a proton‐pump inhibitor(2022)18 cited
- → In Vitro Assessment of Potential for CYP-Inhibition-Based Drug–Drug Interaction Between Vonoprazan and Clopidogrel(2018)17 cited
- → Mutagens and Carcinogens in Food(2018)17 cited